Perspectives on the potential involvement of the Ah receptor-dioxin axis in cardiovascular disease

Toxicological Sciences

Volumn 120, Issue 2, 2011, Pages 256-261

  Puga, Alvaro ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Ah receptor; Cardiovascular disease; Development; Dioxin; NKX2.5

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DIOXIN;

ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL LINEAGE; CONGENITAL HEART MALFORMATION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PATHOGENESIS; PRENATAL EXPOSURE; RECEPTOR INTRINSIC ACTIVITY; RISK FACTOR;

DANIO RERIO; GALLUS GALLUS; MUS;

EID: 79953117928     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfq393     Document Type: Article

References (66)

1. Aragon, A. C., Kopf, P. G., Campen, M. J., Huwe, J. K., and Walker, M. K. (2008). In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on fetal and adult cardiac gene expression and adult cardiac and renal morphology. Toxicol. Sci. 101, 321-330.
2. Armstrong, E. J., and Bischoff, J. (2004). Heart valve development: endothelial cell signaling and differentiation. Circ. Res. 95, 459-470.
3. Barouki, R., Coumoul, X., and Fernandez-Salguero, P. M. (2007). The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett. 581, 3608-3615.
4. Birnbaum, L. S., Harris, M. W., Stocking, L. M., Clark, A. M., and Morrissey, R. E. (1989). Retinoic acid and 2,3,7,8-tetrachlorodibenzo-pdioxin selectively enhance teratogenesis in C57BL/6N mice. Toxicol. Appl. Pharmacol. 98, 487-500.
5. Bock, K. W., and Kohle, C. (2006). Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 72, 393-404.
6. Burbach, K. M., Poland, A., and Bradfield, C. A. (1992). Cloning of the Ahreceptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U.S.A. 89, 8185-8189.
7. Carver, L. A., Jackiw, V., and Bradfield, C. A. (1994). The 90-kDa heat shock protein is essential for Ah receptor signaling in a yeast expression system. J. Biol. Chem. 269, 30109-30112.
8. Dalton, T. P., Kerzee, J. K., Wang, B., Miller, M., Dieter, M. Z., Lorenz, J. N., Shertzer, H. G., Nerbert, D. W., and Puga, A. (2001). Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc. Toxicol. 1, 285-298.
9. Davarinos, N. A., and Pollenz, R. S. (1999). Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export. J. Biol. Chem. 274, 28708-28715.
10. DeVito, M. J., Birnbaum, L. S., Farland, W. H., and Gasiewicz, T. A. (1995). Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals. Environ. Health Perspect. 103, 820-831.
11. Dolk, H., and Vrijheid, M. (2003). The impact of environmental pollution on congenital anomalies. Br. Med. Bull. 68, 25-45.
12. Dummer, T. J., Dickinson, H. O., and Parker, L. (2003). Adverse pregnancy outcomes around incinerators and crematoriums in Cumbria, north west England, 1956-93. J. Epidemiol. Commun. Health 57, 456-461.
13. Elliott, D. A., Kirk, E. P., Yeoh, T., Chandar, S., McKenzie, F., Taylor, P., Grossfeld, P., Fatkin, D., Jones, O., Hayes, P., et al. (2003). Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J. Am. Coll. Cardiol. 41, 2072-2076.
14. Ema, M., Sogawa, K., Watanabe, N., Chujoh, Y., Matsushita, N., Gotoh, O., Funae, Y., and Fujii-Kuriyama, Y. (1992). cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 184, 246-253.
15. Emmons, R. B., Duncan, D., Estes, P. A., Kiefel, P., Mosher, J. T., Sonnenfeld, M., Ward, M. P., Duncan, I., and Crews, S. T. (1999). The spineless-aristapedia and tango bHLH-PAS proteins interact to control antennal and tarsal development in Drosophila. Development 126, 3937-3945.
16. Ferencz, C. (1990). On the birth prevalence of congenital heart disease. J. Am. Coll. Cardiol. 16, 1701-1702.
17. Ferencz, C., and Boughman, J. A. (1993). Congenital heart disease in adolescents and adults. Teratology, genetics, and recurrence risks. Cardiol. Clin. 11, 557-567.
18. Ferencz, C., Boughman, J. A., Neill, C. A., Brenner, J. I., and Perry, L. W. (1989). Congenital cardiovascular malformations: questions on inheritance. Baltimore-Washington Infant Study Group. J. Am. Coll. Cardiol. 14, 756-763.
19. Ferencz, C., and Neill, C. A. (1992). Cardiomyopathy in infancy: observations in an epidemiologic study. Pediatr. Cardiol. 13, 65-71.
20. Fernandez-Salguero, P., Hilbert, D. M., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1996). Aryl hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 140, 173-179.
21. Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 268, 722-726.
22. Fernandez-Salguero, P. M., Ward, J. M., Sundberg, J. P., and Gonzalez, F. J. (1997). Lesions of aryl-hydrocarbon receptor-deficient mice. Vet. Pathol. 34, 605-614.
23. Flesch-Janys, D., Berger, J., Gurn, P., Manz, A., Nagel, S., Waltsgott, H., and Dwyer, J. H. (1995). Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am. J. Epidemiol. 142, 1165-1175.
24. Fujisawa-Sehara, A., Sogawa, K., Yamane, M., and Fujii-Kuriyama, Y. (1987). Characterization of xenobiotic responsive elements upstream from the drugmetabolizing cytochrome P-450c gene: a similarity to glucocorticoid regulatory elements. Nucleic Acids Res. 15, 4179-4191.
25. Gasiewicz, T. A., Henry, E. C., and Collins, L. L. (2008). Expression and activity of aryl hydrocarbon receptors in development and cancer. Crit. Rev. Eukaryot. Gene Expr. 18, 279-321.
26. Gohlke, J. M., Stockton, P. S., Sieber, S., Foley, J., and Portier, C. J. (2009). AhR-mediated gene expression in the developing mouse telencephalon. Reprod. Toxicol. 28, 321-328.
27. Goldberg, S. J., Lebowitz, M. D., Graver, E. J., and Hicks, S. (1990). An association of human congenital cardiac malformations and drinking water contaminants. J. Am. Coll. Cardiol. 16, 155-164.
28. Hahn, M. E. (2002). Aryl hydrocarbon receptors: diversity and evolution. Chem. Biol. Interact. 141, 131-160.
29. Huang, X., Powell-Coffman, J. A., and Jin, Y. (2004). The AHR-1 aryl hydrocarbon receptor and its co-factor the AHA-1 aryl hydrocarbon receptor nuclear translocator specify GABAergic neuron cell fate in C. elegans. Development 131, 819-828.
30. Humblet, O., Birnbaum, L., Rimm, E., Mittleman, M. A., and Hauser, R. (2008). Dioxins and cardiovascular disease mortality. Environ. Health Perspect. 116, 1443-1448.
31. Ivnitski-Steele, I. D., Friggens, M., Chavez, M., and Walker, M. K. (2005). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGFA). Birth Defects Res. A Clin. Mol. Teratol. 73, 440-446.
32. Ivnitski-Steele, I. D., and Walker, M. K. (2005). Inhibition of neovascularization by environmental agents. Cardiovasc. Toxicol. 5, 215-226.
33. Jay, P. Y., Harris, B. S., Maguire, C. T., Buerger, A., Wakimoto, H., Tanaka, M., Kupershmidt, S., Roden, D. M., Schultheiss, T. M., O'Brien, T. X., et al. (2004). Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system. J. Clin. Invest. 113, 1130-1137.
34. Kazlauskas, A., Poellinger, L., and Pongratz, I. (1999). Evidence that the Cochaperone p23 regulates ligand responsiveness of the dioxin (aryl hydrocarbon) receptor. J. Biol. Chem. 274, 13519-13524.
35. Kim, M. D., Jan, L. Y., and Jan, Y. N. (2006). The bHLH-PAS protein Spineless is necessary for the diversification of dendrite morphology of Drosophila dendritic arborization neurons. Genes Dev. 20, 2806-2819.
36. Kogevinas, M., Becher, H., Benn, T., Bertazzi, P. A., Boffetta, P., Bueno-de-Mesquita, H. B., Coggon, D., Colin, D., Flesch-Janys, D., Fingerhut, M., et al. (1997). Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am. J. Epidemiol. 145, 1061-1075.
37. Kuehl, K. S., and Loffredo, C. A. (2005). Genetic and environmental influences on malformations of the cardiac outflow tract. Expert Rev. Cardiovasc. Ther. 3, 1125-1130.
38. Kuehl, K. S., and Loffredo, C. A. (2006). A cluster of hypoplastic left heart malformation in Baltimore, Maryland. Pediatr. Cardiol. 27, 25-31.
39. Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., and Bradfield, C. A. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptordeficient mice. Proc. Natl. Acad. Sci. U.S. A. 97, 10442-10447.
40. Lahvis, G. P., Pyzalski, R. W., Glover, E., Pitot, H. C., McElwee, M. K., and Bradfield, C. A. (2005). The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol. 67, 714-720.
41. Lund, A. K., Goens, M. B., Kanagy, N. L., and Walker, M. K. (2003). Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicol. Appl. Pharmacol. 193, 177-187.
42. Lund, A. K., Goens, M. B., Nunez, B. A., and Walker, M. K. (2006). Characterizing the role of endothelin-1 in the progression of cardiac hypertrophy in aryl hydrocarbon receptor (AhR) null mice. Toxicol. Appl. Pharmacol. 212, 127-135.
43. Lund, A. K., Peterson, S. L., Timmins, G. S., and Walker, M. K. (2005). Endothelin-1-mediated increase in reactive oxygen species and NADPH oxidase activity in hearts of aryl hydrocarbon receptor (AhR) null mice. Toxicol. Sci. 88, 265-273.
44. McElhinney, D. B., Geiger, E., Blinder, J., Benson, D. W., and Goldmuntz, E. (2003). NKX2.5 mutations in patients with congenital heart disease. J. Am. Coll. Cardiol. 42, 1650-1655.
45. Nebert, D. W., Dalton, T. P., Okey, A. B., and Gonzalez, F. J. (2004). Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279, 23847-23850.
46. Pashmforoush, M., Lu, J. T., Chen, H., Amand, T. S., Kondo, R., Pradervand, S., Evans, S. M., Clark, B., Feramisco, J. R., Giles, W., et al. (2004). Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block. Cell 117, 373-386.
47. Perdew, G. H. (1988). Association of the Ah receptor with the 90-kDa heat shock protein. J. Biol. Chem. 263, 13802-13805.
48. Pesatori, A. C., Zocchetti, C., Guercilena, S., Consonni, D., Turrini, D., and Bertazzi, P. A. (1998). Dioxin exposure and non-malignant health effects: a mortality study. Occup. Environ. Med. 55, 126-131.
49. Pollenz, R. S. (1996). The aryl-hydrocarbon receptor, but not the arylhydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and non-hepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzop-dioxin. Mol. Pharmacol. 49, 391-398.
50. Puga, A., Ma, C., and Marlowe, J. L. (2009). The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem. Pharmacol. 77, 713-722.
51. Puga, A., Tomlinson, C. R., and Xia, Y. (2005). Ah receptor signals crosstalk with multiple developmental pathways. Biochem. Pharmacol. 69, 199-207.
52. Qin, H., and Powell-Coffman, J. A. (2004). The Caenorhabditis elegans aryl hydrocarbon receptor, AHR-1, regulates neuronal development. Dev. Biol. 270, 64-75.
53. Reyes, H., Reiz-Porszasz, S., and Hankinson, O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195.
54. Schnekenburger, M., Peng, L., and Puga, A. (2007). HDAC1 bound to the Cyp1a1 promoter blocks histone acetylation associated with Ah receptor-mediated trans-activation. Biochim. Biophys. Acta 1769, 569-578.
55. Schott, J. J., Benson, D. W., Basson, C. T., Pease, W., Silberbach, G. M., Moak, J. P., Maron, B. J., Seidman, C. E., and Seidman, J. G. (1998). Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108-111.
56. Sheiner, E., Katz, M., Fraser, D., Gohar, J., and Carmi, R. (1998). The relationship between congenital cardiovascular malformations and spontaneous abortion in preceding pregnancy. Paediatr. Perinat. Epidemiol. 12, 128-135.
57. Shimizu, Y., Nakatsuru, Y., Ichinose, M., Takahashi, Y., Kume, H., Mimura, J., Fujii-Kuriyama, Y., and Ishikawa, T. (2000). Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc. Natl. Acad. Sci. U.S.A. 97, 779-782.
58. Tanaka, M., Chen, Z., Bartunkova, S., Yamasaki, N., and Izumo, S. (1999). The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 126, 1269-1280.
59. Tanner, K., Sabrine, N., and Wren, C. (2005). Cardiovascular malformations among preterm infants. Pediatrics 116, e833-e838.
60. Taylor, R. T., Wang, F., Hsu, E. L., and Hankinson, O. (2009). Roles of coactivator proteins in dioxin induction of CYP1A1 and CYP1B1 in human breast cancer cells. Toxicol. Sci. 107, 1-8.
61. Tennstedt, C., Chaoui, R., Korner, H., and Dietel, M. (1999). Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 82, 34-39.
62. Thackaberry, E. A., Jiang, Z., Johnson, C. D., Ramos, K. S., and Walker, M. K. (2005a). Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: modulation of cell cycle and extracellular matrix genes. Toxicol. Sci. 88, 231-241.
63. Thackaberry, E. A., Nunez, B. A., Ivnitski-Steele, I. D., Friggins, M., and Walker, M. K. (2005b). Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on murine heart development: alteration in fetal and postnatal cardiac growth, and postnatal cardiac chronotropy. Toxicol. Sci. 88, 242-249.
64. Vena, J., Boffetta, P., Becher, H., Benn, T., Bueno-de-Mesquita, H. B., Coggon, D., Colin, D., Flesch-Janys, D., Green, L., Kauppinen, T., et al. (1998). Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ. Health Perspect. 106(Suppl. 2), 645-653.
65. Wang, Y., Fan, Y., and Puga, A. (2010). Dioxin exposure disrupts the differentiation of mouse embryonic stem cells into cardiomyocytes. Toxicol. Sci. 115, 225-237.
66. Zugerman, C. (1990). Chloracne. Clinical manifestations and etiology. Dermatol. Clin. 8, 209-213.